Back to top

zacks-consensus-estimate: Archive

Zacks Equity Research

What Makes Unilever (UL) a New Buy Stock

Unilever (UL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

ULNegative Net Change

Zacks Equity Research

atai Life Sciences (ATAI) Upgraded to Buy: Here's What You Should Know

atai Life Sciences (ATAI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

ATAIPositive Net Change

Zacks Equity Research

First Commonwealth Financial (FCF) Upgraded to Strong Buy: Here's Why

First Commonwealth Financial (FCF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

FCFPositive Net Change

Zacks Equity Research

Stevanato (STVN) Upgraded to Buy: Here's What You Should Know

Stevanato (STVN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

STVNPositive Net Change

Zacks Equity Research

Primoris Services (PRIM) Upgraded to Buy: Here's Why

Primoris Services (PRIM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

PRIMPositive Net Change

Zacks Equity Research

All You Need to Know About Posco (PKX) Rating Upgrade to Buy

Posco (PKX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

PKXNegative Net Change

Zacks Equity Research

Sphere 3D (ANY) Upgraded to Buy: What Does It Mean for the Stock?

Sphere 3D (ANY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

ANYPositive Net Change

Zacks Equity Research

All You Need to Know About Astria Therapeutics (ATXS) Rating Upgrade to Buy

Astria Therapeutics (ATXS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

ATXSPositive Net Change

Zacks Equity Research

What Makes Vontier (VNT) a New Buy Stock

Vontier (VNT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

VNTPositive Net Change

Zacks Equity Research

Modine (MOD) Upgraded to Strong Buy: What Does It Mean for the Stock?

Modine (MOD) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

MODPositive Net Change

Zacks Equity Research

Why Is Editas (EDIT) Down 16.9% Since Last Earnings Report?

Editas (EDIT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

EDITPositive Net Change GSKPositive Net Change

Zacks Equity Research

Why Is H&R Block (HRB) Up 0.6% Since Last Earnings Report?

H&R Block (HRB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

HRBPositive Net Change

Zacks Equity Research

Theravance Bio (TBPH) Up 9.8% Since Last Earnings Report: Can It Continue?

Theravance Bio (TBPH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

TBPHPositive Net Change UTHRPositive Net Change

Zacks Equity Research

FactSet Research (FDS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

FactSet (FDS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

FDSPositive Net Change

Zacks Equity Research

FedEx (FDX) Reports Next Week: Wall Street Expects Earnings Growth

FedEx (FDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

FDXPositive Net Change

Zacks Equity Research

Earnings Preview: Lennar (LEN) Q3 Earnings Expected to Decline

Lennar (LEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

LENPositive Net Change

Zacks Equity Research

Research Solutions Inc. (RSSS) Earnings Expected to Grow: Should You Buy?

Research Solutions (RSSS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

RSSSPositive Net Change

Zacks Equity Research

Earnings Preview: Scholastic (SCHL) Q1 Earnings Expected to Decline

Scholastic (SCHL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

SCHLPositive Net Change

Zacks Equity Research

Darden Restaurants (DRI) Earnings Expected to Grow: Should You Buy?

Darden Restaurants (DRI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

DRIPositive Net Change PLAYPositive Net Change

Zacks Equity Research

Does Perpetua Resources (PPTA) Have the Potential to Rally 27.71% as Wall Street Analysts Expect?

The mean of analysts' price targets for Perpetua Resources (PPTA) points to a 27.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

PPTAPositive Net Change

Zacks Equity Research

Wall Street Analysts Think Omnicell (OMCL) Could Surge 39.36%: Read This Before Placing a Bet

The average of price targets set by Wall Street analysts indicates a potential upside of 39.4% in Omnicell (OMCL). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

OMCLPositive Net Change

Zacks Equity Research

Wall Street Analysts See a 106.84% Upside in Exodus Movement, Inc. (EXOD): Can the Stock Really Move This High?

The mean of analysts' price targets for Exodus Movement, Inc. (EXOD) points to a 106.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

EXODNegative Net Change

Zacks Equity Research

Earnings Growth & Price Strength Make Quanta Services (PWR) a Stock to Watch

The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.

PWRPositive Net Change

Zacks Equity Research

Vera Bradley (VRA) Reports Q2 Loss, Lags Revenue Estimates

Vera Bradley (VRA) delivered earnings and revenue surprises of +86.67% and -9.76%, respectively, for the quarter ended July 2025. Do the numbers hold clues to what lies ahead for the stock?

VRANegative Net Change LEVIPositive Net Change

Zacks Equity Research

Kroger (KR) Tops Q2 Earnings Estimates

Kroger (KR) delivered earnings and revenue surprises of +4.00% and -0.54%, respectively, for the quarter ended July 2025. Do the numbers hold clues to what lies ahead for the stock?

KRNegative Net Change SFIXNegative Net Change